Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

2.45
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
1.50
Today|||52-Week Range
6.38
-50.00%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close2.45
Today’s open2.45
Day’s range2.40 - 2.55
Volume497,648
Average volume (3 months)966,584
Market cap$194.3M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)+2.42%
Earnings growth (this year)--
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+77.60%
P/E ratioNM
Price/Sales30.27
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
MTNBMatinas BioPharma Ho...0.000.00%
VTLVital Therapies Inc0.000.00%
--Verona Pharma PLC-0.02-1.99%
PRQRProQR Therapeutics N...0.000.00%
Data as of 8:00pm ET, 11/17/2017

Financials

Next reporting dateNovember 20, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$8.2M
Annual profit (last year)-$60.9M
Net profit margin-747.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Henry H. Ji
Chief Financial Officer
John Liatos
Corporate headquarters
San Diego, California

Forecasts